John Rotrosen

Biosketch / Results /

John Rotrosen

Professor, Department of Psychiatry
Dir Addiction Research Center

Contact Info

Address
1 Park Avenue
New York, NY 10016

646/754-4763
John.Rotrosen@nyumc.org


Research Summary

Dr. John Rotrosen is Professor of Psychiatry at New York University School of Medicine. He attended NYU School of Medicine from 1968 to 1972 and completed a Psychiatry Research Residency at NYU and Bellevue Hospital in 1976. Subsequent research training was supported in part by an NIMH Research Scientist Career Development Award under the mentorship of Drs. Samuel Gershon and Burt Angrist. From 1980 through 1997 Dr. Rotrosen served as Chief, Psychiatry Service at the VA Medical Center in New York where he is now Associate Chief of Staff for Mental Health Research. Dr. Rotrosen and his collaboratorsa?? research has focused on addictive disorders, attention deficit hyperactivity disorder and schizophrenia and movement disorders, addressing pathophysiology, pharmacological and behavioral intervention, and translation to community settings. His research group has contributed to the development of nearly all of the novel antipsychotic agents and to the development of new medications, novel forms of medication delivery, and behavioral therapies for opiate, cocaine, alcohol and nicotine dependence. Dr. Rotrosen is Principal Investigator of the New York Node of the NIDA Clinical Trials Network and Director of the Center of Excellence on Addiction at NYU Langone Medical Center. http://coe.addiction.med.nyu.edu/

Research Interests

Addiction, Biological Psychiatry, Psychopharmacology, Behavioral Inverventions, Clinical Neuroscience

EXTENDED-RELEASE NALTREXONE VERSUS ORAL NALTREXONE FOR ALCOHOL USE DISORDER TREATMENT IN PRIMARY CARE
Chen, J; Obi, R; Wong, S; Flannery, M; McDonald, R; Tofighi, B; Kermack, A; Laska, E; Rotrosen, J; Gourevitch, MN. EXTENDED-RELEASE NALTREXONE VERSUS ORAL NALTREXONE FOR ALCOHOL USE DISORDER TREATMENT IN PRIMARY CARE [Meeting Abstract]. Alcoholism: clinical & experimental research. 2016 JUN;40:233A-233A (2219942)

Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients
Kumar, Pritika C; Cleland, Charles M; Gourevitch, Marc N; Rotrosen, John; Strauss, Shiela; Russell, Linnea; McNeely, Jennifer. Accuracy of the Audio Computer Assisted Self Interview version of the Alcohol, Smoking and Substance Involvement Screening Test (ACASI ASSIST) for identifying unhealthy substance use and substance use disorders in primary care patients. Drug & alcohol dependence. 2016 Jun 22;165:38-44 (2167262)

Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders
Lee, Joshua D; Friedmann, Peter D; Kinlock, Timothy W; Nunes, Edward V; Boney, Tamara Y; Hoskinson, Randall A Jr; Wilson, Donna; McDonald, Ryan; Rotrosen, John; Gourevitch, Marc N; Gordon, Michael; Fishman, Marc; Chen, Donna T; Bonnie, Richard J; Cornish, James W; Murphy, Sean M; O'Brien, Charles P. Extended-Release Naltrexone to Prevent Opioid Relapse in Criminal Justice Offenders. New England journal of medicine. 2016 Mar;374(13):1232-1242 (2079662)

NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale
Lee, Joshua D; Nunes, Edward V; Mpa, Patricia Novo; Bailey, Genie L; Brigham, Gregory S; Cohen, Allan J; Fishman, Marc; Ling, Walter; Lindblad, Robert; Shmueli-Blumberg, Dikla; Stablein, Don; May, Jeanine; Salazar, Dagmar; Liu, David; Rotrosen, John. NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale. Contemporary clinical trials. 2016 Aug 10;50:253-264 (2219212)

African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction
Levran, Orna; Randesi, Matthew; Peles, Einat; Correa da Rosa, Joel; Ott, Jurg; Rotrosen, John; Adelson, Miriam; Kreek, Mary Jeanne. African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction. Pharmacogenomics. 2016 Jun;17(9):995-1003 (2175702)